BOSTON--(BUSINESS WIRE)--ScyFIX, a Minnesota-based medical device venture specializing in minimally invasive treatments for blindness-causing diseases, announced upcoming clinical trials at the Medtech Insight In3 East Conference. The company’s device has shown efficacy in treating Age-Related Macular Degeneration (AMD) and Glaucoma.
